Optimization of the Sensitivity of Histological Diagnosis of Pulmonary Nodules

NACompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

November 5, 2022

Primary Completion Date

November 30, 2023

Study Completion Date

December 31, 2023

Conditions
Nodule
Interventions
DEVICE

Cryoprobes First

In this experimental group, the Cryoprobe is used in first and the classic biopsy forceps in a second time. This medical device under study is the flexible, single-use Cryoprobe, supplied in sterile condition, 1.1 mm in diameter, 1150 mm long, with extraction tube, 817 mm long (reference 20402-401), or 757 mm long (reference 20402-402) marketed. These cryoprobes are covered by a CE marking. Cryoprobes must be used in conjunction with the Erbecryo®2 device and its accessories.

DEVICE

Cryoprobes Second

In this second experimental group, the same medical devices are used but in the other order.

Trial Locations (1)

44800

Pneumologie Elsan Santé Atlantique, Saint-Herblain

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Elsan

OTHER